Results 31 to 40 of about 170,643 (213)

Glucose-Potentiated Amikacin Killing of Cefoperazone/Sulbactam Resistant Pseudomonas aeruginosa

open access: yesFrontiers in Microbiology, 2022
Multidrug-resistant Pseudomonas aeruginosa has become one of global threat pathogens for human health due to insensitivity to antibiotics. Recently developed reprogramming metabolomics can identify biomarkers, and then, the biomarkers were used to revert
Xi-kang Tang   +13 more
doaj   +1 more source

Antibiotic Sensitivity Testing and Molecular Characteristics Related to Clarithromycin and Amikacin Resistance in Mycobacterium abscessus Complex Isolated from Patients with Pulmonary Infection at National Hospital 74, Vietnam

open access: yesInternational Journal of Mycobacteriology
Background: Mycobacterium abscessus complex (MABC) is an important cause of opportunistic infections in the respiratory tracts. Data on antimicrobial resistance of MABC in Vietnam were still lacking. Methods: From December 2021 to July 2022, mycobacteria
Vu Thi Thuong   +6 more
doaj   +1 more source

Nocardia transvalensis keratitis: an emerging pathology among travelers returning from Asia

open access: yesBMC Infectious Diseases, 2011
Background The incidence rate of Nocardia keratitis is increasing, with new species identified thanks to molecular methods. We herein report a case of Nocardia transvalensis keratitis, illustrating this emerging pathology among travellers returning from ...
Trichet Elodie   +4 more
doaj   +1 more source

Incidence of Acute Kidney Injury in Autologous Hematopoietic Stem Cell Transplant Recipients According to the Administration of Empirical Amikacin: A Two-Centre Retrospective Cohort Study

open access: yesAntibiotics
Background: The benefit of adjunctive aminoglycosides in the treatment of patients with febrile neutropenia (FN) is controversial. We investigated the incidence of acute kidney injury (AKI) in patients with FN or suspected infection according to ...
Sophie Schürch   +10 more
doaj   +1 more source

Exposure of Mycobacterium abscessus to Environmental Stress and Clinically Used Antibiotics Reveals Common Proteome Response among Pathogenic Mycobacteria

open access: yesMicroorganisms, 2020
Mycobacterium abscessus subsp. abscessus (MAB) is a clinically important nontuberculous mycobacterium (NTM) causing pulmonary infection in patients such as cystic fibrosis and bronchiectasis.
Rajoana Rojony   +5 more
doaj   +1 more source

Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages

open access: yesFrontiers in Microbiology, 2018
Non-tuberculous mycobacteria (NTM) cause pulmonary infections in patients with structural lung damage, impaired immunity, or other risk factors. Delivering antibiotics to the sites of these infections is a major hurdle of therapy because pulmonary NTM ...
Jimin Zhang   +9 more
semanticscholar   +1 more source

Kidney Organoids in Drug Development: Integrating Technological Advances and Standardization for Effective Implementation

open access: yesAdvanced Healthcare Materials, EarlyView.
This review examines how emerging enabling technologies enhance the physiological relevance, scalability, and reproducibility of kidney organoids, while advanced analytical approaches support model validation and deepen mechanistic insight into nephrotoxicity.
Helen Kearney   +3 more
wiley   +1 more source

Perbandingan Efektivitas Kombinasi Ceftazidime + Amikasin dan Ceftazidime sebagai Antibiotik Empiris Demam Neutropenia pada Keganasan

open access: yesSari Pediatri, 2016
Latar belakang. Terapi antibiotik empiris spektrum luas merupakan standar pengobatan demam neutropenia pada keganasan karena morbiditas dan mortalitas yang berhubungan dengan sepsis bakterial.
Agustinus William   +3 more
doaj   +1 more source

Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa

open access: yesAntibiotics, 2021
Pseudomonas aeruginosa is an opportunistic nosocomial pathogen associated with high morbidity and mortality rates. Combination of antibiotics has been found to combat multi-drug resistant or extensively drug resistance P. aeruginosa.
Sara Mahmoud Farhan   +6 more
doaj   +1 more source

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

open access: yesAdvanced Materials, EarlyView.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy